Plant-Based
Cell Based Tech Weekly – BlueNalu’s Pilot Facility, Codexis x Molecular Assemblies, Impossible Breakfast Coming to Starbucks
BlueNalu is putting their recent Series A funding of $20 million to work through the expansion of its pilot facility in San Diego and the expansion of…
BlueNalu is putting their recent Series A funding of $20 million to work through the expansion of its pilot facility in San Diego and the expansion of its team (plans to double the company staff to ~50 team members). https://cellbased.link/at7
What We Know:
- BlueNalu’s pilot facility will feature various bioreactors ranging in sizes from 10 to 2,000 liters
- BlueNalu will manufacture equipment that combine processes from 3D bioprinting and food extrusion.
- The new facility will have cell cultures from R&D scale up to 2000 liters
- BlueNalu will produce seafood products for a test market
Too Soon to Tell: BlueNalu has yet to confirm how many lbs of meat scaling to 2,000 liters would yield and what the price point would be at this capacity.
Investments
Protein engineering company Codexis, Inc. (Nasdaq: CDXS) and Molecular Assemblies, Inc., announced a partnership through which Codexis will purchase $1 million in Series A preferred stock of Molecular Assemblies. The two companies will work together to leverage the Codexis CodeEvolver® protein engineering platform to develop custom designed enzymes for DNA synthesis. https://cellbased.link/zfe
Background: DNA Synthesis has historically been done through chemical processing. Molecular Assemblies is working on synthesizing DNA enzymatically, which enables longer gene lengths and higher accuracy as opposed to chemical synthesis (requires harsh solvents and cannot stitch longer gene lengths).
Why We Care: The possibilities to create larger amounts of high-quality DNA enables more advancements in synthetic biology innovations in agriculture, textiles and material sectors. The market for traditional chemical DNA synthesis today is about $2 billion annually (enzymatically synthesized DNA is not yet on the market, https://cellbased.link/vt4)
Advancements
This week, Impossible Foods reached a new milestone with the launch of an Impossible Breakfast Sandwich at Starbucks internationally and at most U.S. locations.
- According to an interview with CNBC, Impossible Foods CEO, Pat Brown stated the Starbucks deal is by far the biggest launch for the company thus far (bigger than Burger King!).
Regulation
The Japanese Agriculture, Forestry and Fisheries Ministry is working towards a legislation strategy for the next generation sources of protein, including alternative and cultured meat, algae and insects. https://cellbased.link/2nm
- In July, the government and the private sector will set up a council to study how to label products sold at supermarkets and other retail outlets and how to standardize the specifications.
The post Cell Based Tech Weekly – BlueNalu’s Pilot Facility, Codexis x Molecular Assemblies, Impossible Breakfast Coming to Starbucks appeared first on Cell Based Tech.
cultured meat bluenalu impossible foods meat seafood burger protein alternative cultured bioprinting cell based funding nasdaq
Are fish oil supplements as healthy as we think? And is eating fish better?
Thanks to These 19 Brands, It’s Easier Than Ever To Go Vegan With An Allergy
Turmeric Could Relieve Indigestion As Effectively As Drugs, Says Study
Sponsored Post Health Advantages of Oats: A Nutrient-Packed Superfood
What Happened to the Beyond Meat and Oatly Stocks and What You Need To Know Before Your Company IPOs
Starbucks Is Pivoting to Reusable Cups. Here’s Why Dairy Has To Go, Too.
Smart Menus: How to Get Meat Eaters To Choose Plant-Based Dishes
Vegan Bacon: What Brands Are Best, What’s It Made Of, And Is It Healthy?
Study Finds Singaporean Meat Consumers Prefer the Term ‘Cultivated Meat’
